Lung Cancer in Vietnam Faces Late Detection Challenges Amid Medical Advancements

Late Diagnosis Remains a Major Obstacle for Lung Cancer Patients in Vietnam

Ung thư phổi continues to be a leading cause of cancer-related deaths in Vietnam, with over 24,000 new cases diagnosed annually and nearly 22,600 fatalities. According to Dr. Diệp Bảo Tuấn, director of Ho Chi Minh City Cancer Hospital, the disease is often detected at advanced stages due to its lack of early symptoms.

These symptoms, when present, are frequently mistaken for common respiratory conditions, leading to delayed treatment. This pattern underscores a critical gap in early detection, which significantly impacts patient outcomes. The challenge is compounded by the fact that many patients are only diagnosed after the cancer has spread, a phase where treatment options are limited and survival rates drop sharply.

Dr. Lê Tuấn Anh, head of the Oncology Center at Chợ Rẫy Hospital, highlighted that lung cancer ranks among the top three cancers in Vietnam, yet its early-stage subtlety makes it difficult to catch. Without timely intervention, the prognosis worsens, creating a cycle of late diagnosis and poor survival.

Targeted Therapies and AI Revolutionize Lung Cancer Treatment Strategies

Recent advancements in medical science are reshaping the treatment landscape for lung cancer patients. Dr. Phạm Xuân Dũng, president of the Ho Chi Minh City Cancer Association, noted that targeted therapies and immunotherapy are now being applied to earlier stages of the disease, shifting the focus from merely extending life to achieving long-term remission.

These precision treatments, tailored to individual genetic profiles, have already extended survival rates from under 12 months to several years in some cases. The integration of artificial intelligence (AI) into diagnostic processes is another breakthrough. AI tools are now capable of analyzing medical imaging with greater accuracy, enabling earlier identification of tumors and more precise treatment planning.

Dr. Dũng highlighted that AI’s role in streamlining diagnostics and personalizing care is critical to improving patient outcomes. This technology also allows for faster decision-making, which is essential in a disease where early intervention is key.

Call for Early Screening and Public Awareness to Combat Rising Lung Cancer Rates

Experts warn that without a cultural shift toward proactive health management, Vietnam’s lung cancer crisis will persist. Dr. Dũng urged the Ministry of Health to prioritize policies that promote regular screenings and public education about risk factors such as smoking and environmental exposure.

He emphasized that early detection remains the most effective way to reduce mortality, yet current systems lack the capacity to scale these initiatives nationwide. Public awareness campaigns are also critical. Many patients delay seeking care due to stigma or a lack of knowledge about symptoms.

Dr. Tuấn Anh pointed out that improving communication about the disease’s progression and treatment options could encourage earlier consultations. Additionally, integrating cancer education into school curricula and workplace wellness programs could foster a more informed population.

Conclusion

The struggle against lung cancer in Vietnam hinges on bridging the gap between medical progress and public health infrastructure. While advancements in targeted therapies and AI offer hope, the disease’s high mortality rate underscores the urgent need for early detection and education. Addressing these challenges will require a coordinated effort to transform late diagnosis into a thing of the past.

Read more: National Assembly Prepares for Historic First Session Amid Key Legislative and Economic Challenges